Your browser doesn't support javascript.
loading
High-Speed Screening of Lipoprotein Components Using Online Miniaturized Asymmetrical Flow Field-Flow Fractionation and Electrospray Ionization Tandem Mass Spectrometry: Application to Hepatocellular Carcinoma Plasma Samples.
Kim, Jin Yong; Lee, Gwang Bin; Lee, Jong Cheol; Moon, Myeong Hee.
Affiliation
  • Kim JY; Department of Chemistry, Yonsei University, Seoul 03722, Republic of Korea.
  • Lee GB; Department of Chemistry, Yonsei University, Seoul 03722, Republic of Korea.
  • Lee JC; Department of Chemistry, Yonsei University, Seoul 03722, Republic of Korea.
  • Moon MH; Department of Chemistry, Yonsei University, Seoul 03722, Republic of Korea.
Anal Chem ; 93(11): 4867-4875, 2021 03 23.
Article in En | MEDLINE | ID: mdl-33689313
ABSTRACT
This study introduces a high-speed screening method for the quantitative analysis of lipoprotein components in human plasma samples using online miniaturized asymmetrical flow field-flow fractionation and electrospray ionization-tandem mass spectrometry (mAF4-ESI-MS/MS). Using an mAF4 channel, high-density lipoproteins and low-density lipoproteins can be fractionated by size at a high speed (<10 min) and directly fed to ESI-MS/MS for the simultaneous screening of targeted lipid species and apolipoprotein A1 (ApoA1). By employing the heated electrospray ionization probe as an ionization source, an mAF4 effluent flow rate of up to a few tens of microliters per minute can be used, which is adequate for direct feeding to MS without splitting the outflow, resulting in a consistent feed rate to MS for stable MS detection. mAF4-ESI-MS/MS was applied to hepatocellular carcinoma (HCC) plasma samples for targeted quantification of 25 lipid biomarker candidates and ApoA1 compared with healthy controls, the results of which were in statistical agreement with the quantified results obtained by nanoflow ultrahigh performance liquid chromatography-tandem mass spectrometry. Moreover, the present method provided the simultaneous detection of changes in lipoprotein size and the relative amount. This study demonstrated the potential of mAF4-ESI-MS/MS as an alternative high-speed screening platform for the top-down analysis of targeted lipoprotein components in patients with HCC, which is applicable to other diseases that involve the perturbation of lipoproteins.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Liver Neoplasms Type of study: Diagnostic_studies / Screening_studies Limits: Humans Language: En Journal: Anal Chem Year: 2021 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Liver Neoplasms Type of study: Diagnostic_studies / Screening_studies Limits: Humans Language: En Journal: Anal Chem Year: 2021 Type: Article